- £99.63m
- £93.83m
- £20.12m
2018 December 31st | 2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6.19 | 8.66 | 13 | 16.7 | 20.1 |
Cost of Revenue | |||||
Gross Profit | 3.19 | 4.46 | 9.09 | 11.6 | 13.9 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 6.26 | 9.56 | 14.6 | 17.4 | 21 |
Operating Profit | -0.066 | -0.902 | -1.63 | -0.733 | -0.912 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.389 | -1.29 | -1.95 | -0.72 | -0.831 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.143 | -0.923 | -1.48 | -0.31 | -0.716 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -0.234 | -1.08 | -1.48 | -0.31 | -0.716 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.234 | -1.08 | -1.48 | -0.31 | -0.716 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.004 | -0.028 | -0.045 | -0.009 | -0.022 |
Dividends per Share |